Neutrophil-related gene expression and low-density granulocytes associated with disease activity and response to treatment in antineutrophil cytoplasmic antibody-associated vasculitis

Arthritis and Rheumatology

Volumn 67, Issue 7, 2015, Pages 1922-1932

  Grayson, Peter C ^a   Carmona Rivera, Carmelo ^a   Xu, Lijing ^b   Lim, Noha ^b   Gao, Zhong ^b   Asare, Adam L ^b   Specks, Ulrich ^c   Stone, John H ^d   Seo, Philip ^e   Spiera, Robert F ^f   Langford, Carol A ^g   Hoffman, Gary S ^g   Kallenberg, Cees G M ^h   St Clair, E William ⁱ   Tchao, Nadia K ^b   Ytterberg, Steven R ^c   Phippard, Deborah J ^b   Merkel, Peter A ^j   Kaplan, Mariana J ^a   Monach, Paul A ^k  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b Immune Tolerance Network   (United States)

^c MAYO CLINIC   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f HOSPITAL FOR SPECIAL SURGERY   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h UNIVERSITY OF GRONINGEN   (Netherlands)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZUROCIDIN; CATHELICIDIN; CATHEPSIN G; DEFENSIN; ELASTASE; HEMOGLOBIN; LACTOFERRIN; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PREDNISONE; BIOLOGICAL MARKER; GLUCOCORTICOID; LEUKOCYTE ELASTASE; PEROXIDASE;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; CELL POPULATION; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; ENZYME BLOOD LEVEL; EXTRACELLULAR TRAP; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GRANULOCYTE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; TREATMENT RESPONSE; UPREGULATION; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; BIOMARKERS; EXTRACELLULAR TRAPS; FEMALE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; GRANULOCYTES; HUMANS; LEUKOCYTE ELASTASE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYELOBLASTIN; PEROXIDASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84933055926     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39153     Document Type: Article

References (38)

1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al., 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65: 1-11.
2. Hoffman GS, Leavitt RY, Fleisher TA, Minor JR, Fauci AS., Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 1990; 89: 403-10.
3. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al., Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010; 363: 221-32.
4. Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, et al., Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med 2013; 369: 417-27.
5. Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al., Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 2005; 143: 621-31.
6. McKinney EF, Lyons PA, Carr EJ, Hollis JL, Jayne DR, Willcocks LC, et al., A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med 2010; 16: 586-91.
7. Li ZY, Chang DY, Zhao MH, Chen M., Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated vasculitis: a study of 439 cases in a single Chinese center. Arthritis Rheumatol 2014; 66: 1920-6.
8. Pagnoux C, Hogan SL, Chin H, Jennette JC, Falk RJ, Guillevin L, et al., Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts. Arthritis Rheum 2008; 58: 2908-18.
9. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, et al, for the EC/BCR Project for ANCA Assay Standardization. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998; 53: 743-53.
10. Tomasson G, Grayson PC, Mahr AD, LaValley M, Merkel PA., Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis-a meta-analysis. Rheumatology (Oxford) 2012; 51: 100-9.
11. Falk RJ, Jennette JC., ANCA disease: where is this field heading? J Am Soc Nephrol 2010; 21: 745-52.
12. Falk RJ, Terrell RS, Charles LA, Jennette JC., Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 1990; 87: 4115-9.
13. Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, et al., The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 2005; 167: 39-45.
14. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, et al., Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clinical Invest 2002; 110: 955-63.
15. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al., Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532-5.
16. Remijsen Q, Kuijpers TW, Wirawan E, Lippens S, Vandenabeele P, Vanden Berghe T., Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ 2011; 18: 581-8.
17. Kaplan MJ, Radic M., Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol 2012; 189: 2689-95.
18. Brinkmann V, Zychlinsky A., Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biology 2012; 198: 773-83.
19. Nakazawa D, Shida H, Tomaru U, Yoshida M, Nishio S, Atsumi T, et al., Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis. J Am Soc Nephrol 2014; 25: 990-7.
20. Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, et al., Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 2009; 15: 623-5.
21. Kelley JM, Monach PA, Ji C, Zhou Y, Wu J, Tanaka S, et al., IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proc Natl Acad Sciences U S A 2011; 108: 20736-41.
22. Nakazawa D, Tomaru U, Yamamoto C, Jodo S, Ishizu A., Abundant neutrophil extracellular traps in thrombus of patient with microscopic polyangiitis. Front Immunol 2012; 3: 333.
23. Carmona-Rivera C, Kaplan MJ., Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity. Semin Immunopathol 2013; 35: 455-63.
24. Denny MF, Yalavarthi S, Zhao W, Thacker SG, Anderson M, Sandy AR, et al., A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol 2010; 184: 3284-97.
25. Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, et al., Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011; 187: 538-52.
26. Carmona-Rivera C, Zhao W, Yalavarthi S, Kaplan MJ., Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann Rheum Dis 2014. E-pub ahead of print.
27. Cheadle C, Berger AE, Andrade F, James R, Johnson K, Watkins T, et al., Transcription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener's granulomatosis. Arthritis Rheum 2010; 62: 1744-54.
28. Lyons PA, McKinney EF, Rayner TF, Hatton A, Woffendin HB, Koukoulaki M, et al., Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis. Ann Rheum Dis 2010; 69: 1208-13.
29. Vartanian K, Slottke R, Johnstone T, Casale A, Planck SR, Choi D, et al., Gene expression profiling of whole blood: comparison of target preparation methods for accurate and reproducible microarray analysis. BMC Genomics 2009; 10: 2.
30. Langmead B, Trapnell C, Pop M, Salzberg SL., Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009; 10: R25.
31. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al., The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
32. WGET Research Group. Design of the Wegener's Granulomatosis Etanercept Trial (WGET). Control Clin Trials 2002; 23: 450-68.
33. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al., Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.
34. Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, et al, for the International Network for the Study of the Systemic Vasculitides (INSSYS). A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. Arthritis Rheum 2001; 44: 912-20.
35. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102: 15545-50.
36. Ohlsson S, Hellmark T, Pieters K, Sturfelt G, Wieslander J, Segelmark M., Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis. Clin Exp Immunol 2005; 141: 174-82.
37. Muller Kobold AC, Kallenberg CG, Cohen Tervaert JW., Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis. Br J Rheumatol 1998; 37: 901-7.
38. Nakagawa M, Terashima T, D'Yachkova Y, Bondy GP, Hogg JC, van Eeden SF., Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes. Circulation 1998; 98: 2307-13.